<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Classification criteria for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> were first proposed in 1987, revised in 1999 (Sapporo criteria) and up-dated in 2006 </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to analyze associations between clinical and laboratory symptoms of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in the group of patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, based on recently up-dated classification criteria </plain></SENT>
<SENT sid="2" pm="."><plain>336 patients were enrolled into the study, with the majority (n=235) suffering from SLE </plain></SENT>
<SENT sid="3" pm="."><plain>Laboratory determinations included: <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), anticardiolipin (aCL) and anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (abeta2GPI) (both of IgG and IgM class) </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical and laboratory symptoms of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> were quite common among patients studied </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant association between laboratory and clinical features of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, according to recently modified classification criteria </plain></SENT>
</text></document>